Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma

Gender PreferenceNone
Age Group18 - 99 years
Research Start DateOctober 22, 2012
Research End DateOctober 22, 2022
Principal InvestigatorMohammed Milhem, MD
Description

Participants in this research study have been diagnosed with a type of soft tissue sarcoma called liposarcoma that has spread to other parts of the body or is not able to be removed with surgery. This research study is being performed at about 8 clinics across the United States and approximately 38 people will participate. The purpose of the study is to see if the study drug pazopanib is safe and effective with subjects with liposarcoma. 

Contact Info

Mohammed Milhem, 319-356-2324

Keywordsspan itemProp='description'>Adipose tissue ; Cancer ; Connective Tissue ; IRB#201205509 ; Liposarcoma ; Metastatic Liposarcoma ; Milhem ; Neoplasms ; Pazopanib ; Phase 2 ; Phase II ; Sarcoma ; Soft Tissue ; Soft tissue sarcoma ; Surgically Unresectable Liposarcoma ;